Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.105 USD | -0.85% | -5.31% | -83.50% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
MarketScreener Editorial Features
Today on Wall Street: Inflation and pricing power | June 15, 2021 at 09:21 am | |
ANALYST RECOMMENDATIONS : Anglo American, Pfizer, Rolls-Royce, Nike, Oatly... | June 15, 2021 at 06:22 am |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- MarketScreener Editorial Features